A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges over an alleged scheme to hide federal records during the COVID-19 pandemic, the Justice Department said Tuesday.
Dr. David Morens, 78, was indicted by a federal grand jury earlier this month and charged with five counts, including conspiracy, destruction of records in federal investigations, and concealment of records. He made his initial appearance before a federal magistrate judge Monday and is set to be arraigned next week.
Morens served as a senior adviser to NIAID's Office of the Director from 2006 through 2022. Dr. Anthony Fauci led the institute for nearly 40 years, serving under seven presidents, and retired in 2022 during then-President Joe Biden's administration.
Prosecutors allege that Morens and two unnamed, unindicted co-conspirators worked together to defraud the U.S. by shielding federal records related to the pandemic from the public. The first co-conspirator, identified as "co-conspirator 1," served as the president and CEO of a New York-based nonprofit group that received a grant in 2014 titled "Understanding the Risk of Bat Coronavirus Emergence."
Health Glance
Donald Trump has selected Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC), bringing to an end a months-long search for a permanent head of the troubled public health agency.
The Supreme Court sided with a Christian counselor on Tuesday in her free speech challenge to Colorado’s ban on counselors attempting to change a minor’s sexual orientation or gender identity.
Since September, 16 major drug companies have inked deals with the Trump administration to lower prices. But in January — the time of year when pharmaceutical companies typically roll out price hikes — all 16 companies released higher list prices for some of their drugs.
With subsidies for Affordable Care Act (ACA) health insurance set to expire, Americans who rely on them will probably switch to plans with lower monthly premiums and high deductibles or decide not to purchase any coverage, which will have a serious and damaging impact on the entire sector, according to healthcare policy experts.





























